Delivery Order SPE2DB22D9239-SPE2DB24FDJ13
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,807.43 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Jakafi 25 mg tablet prescription drugs. The award was made under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FPQH2 with DLA, which has a potential ceiling value of $4,999,999 and supports the recurring pharmaceutical supply needs of military health facilities worldwide. DMS...
- The U.S. Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the drug Jakafi 20 mg tablet in 60-count packages. The $11,794.12 contract has a completion date of January 24, 2024. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple indefinite delivery contracts with the Defense Logistics Agency to supply a wide range of pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,564,071,750 units of the pharmaceutical drug Jakafi 15 mg tablet. The delivery order falls under the larger DLA SPE2DB Indefinite Delivery Vehicle (IDV), a multi-year contract valued at up to $4,999,999 that enables DLA to fulfill recurring medical supply needs for military health facilities. DMS...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Jakafi 5 mg tablet 60s. The contract has a potential value of $71,098.86 and a completion date of January 23, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple indefinite delivery contracts with the Defense Logistics Agency to supply a variety...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,652,559 tablets of the pharmaceutical product Jakafi 5 mg. The $12,296.20 contract has a completion date of February 2, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to deliver a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,054.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Jakafi 10 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of military health...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 contract is to provide the DLA with 4,556,044,091 units of the drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price orders for a...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jakafi 25 mg tablets. The $219,155.28 order is part of a larger indefinite delivery contract with DLA Troop Support Medical to supply pharmaceuticals and medical products for military treatment facilities. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple contracts to deliver brand name and generic drugs, surgical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of 10 mg Jakafi tablets to fulfill the medical supply needs of the U.S. military. DMS Pharmaceutical Group holds a separate $4,999,999 indefinite delivery contract with DLA to provide a broad range of pharmaceutical products and biologics to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,549.43 contract is for the delivery of the prescription drug Jakafi 5 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDJ13Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Jakafi 10 mg tablets. The $47,371.79 contract has an ultimate completion date of April 24, 2024. DMS Pharmaceutical Group specializes in providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies to support the recurring medical needs of military health facilities and VA medical centers. This delivery order contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, for a comprehensive range of pharmaceutical items to fulfill the medical supply requirements of the Department of Defense. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.4k | 4/23/24 |